Background: To describe a novel surgical technique for add-on sulcus implantation of the Smaller-Incision New Generation Implantable Miniature Telescope (SING IMT™) in pseudophakic eyes with end-stage age-related macular degeneration (AMD). Methods: Two pseudophakic patients with bilateral end-stage AMD underwent add-on SING IMT™ implantation in the ciliary sulcus. Pre- and postoperative evaluations included best-corrected distance visual acuity (BCDVA), anterior segment OCT (AS-OCT), corneal endothelial cell counts, and subjective visual function assessments, with follow-up to 6 months. Results: Both surgeries were uneventful. The devices remained stable and well-centered with no significant inflammation, corneal decompensation, or intraocular pressure elevation. BCDVA improved by 3–4 ETDRS lines, and both patients reported improved daily visual function. Corneal endothelial loss was < 5% at 6 months. Conclusions: Add-on sulcus implantation of the SING IMT™ in pseudophakic eyes is surgically feasible and well tolerated, expanding the potential indications of this visual rehabilitation device to a broader AMD population.
Add-on implantation of the smaller-incision new generation implantable miniature telescope (SING IMT™) in pseudophakic eyes
Pellegrini, MarcoPrimo
;Adamo, Ginevra Giovanna;Cartabellotta, Antonio;Crisafulli, Sabrina;Parmeggiani, Francesco;Mura, Marco
Ultimo
2026
Abstract
Background: To describe a novel surgical technique for add-on sulcus implantation of the Smaller-Incision New Generation Implantable Miniature Telescope (SING IMT™) in pseudophakic eyes with end-stage age-related macular degeneration (AMD). Methods: Two pseudophakic patients with bilateral end-stage AMD underwent add-on SING IMT™ implantation in the ciliary sulcus. Pre- and postoperative evaluations included best-corrected distance visual acuity (BCDVA), anterior segment OCT (AS-OCT), corneal endothelial cell counts, and subjective visual function assessments, with follow-up to 6 months. Results: Both surgeries were uneventful. The devices remained stable and well-centered with no significant inflammation, corneal decompensation, or intraocular pressure elevation. BCDVA improved by 3–4 ETDRS lines, and both patients reported improved daily visual function. Corneal endothelial loss was < 5% at 6 months. Conclusions: Add-on sulcus implantation of the SING IMT™ in pseudophakic eyes is surgically feasible and well tolerated, expanding the potential indications of this visual rehabilitation device to a broader AMD population.| File | Dimensione | Formato | |
|---|---|---|---|
|
2026 - 1- s40942-025-00797-9.pdf
accesso aperto
Tipologia:
Full text (versione editoriale)
Licenza:
Creative commons
Dimensione
1.1 MB
Formato
Adobe PDF
|
1.1 MB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


